Trial intelligence / Profile preview

Intravenous Vitamin C in Advanced Non-Small Cell Lung Cancer

NCT05849129Phase 2Terminated

Sponsor
Canadian College of Naturopathic Medicine
Start
Oct 2024
Primary completion
Sep 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ascorbic acid in non-small cell lung cancer (NSCLC), sponsored by Canadian College of Naturopathic Medicine. Started Oct 2024; status: terminated.

02

Drugs

ascorbic acid
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT05849129.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05849129.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call